2Grusch M,Polgar D,Gfatter S,et al.Maintenance of ATP favours apoptosis over necrosis triggered by benzamide riboside.Cell Death Differ,2002,9:169-178.
3Gharehbaghi K,Sreenath A,Hao Z,et al.Comparison of biochemical parameters of benzamide riboside,a new inhibitor of IMP dehydrogenase,with tiazofurin and selenazofurin.Biochem Pharmacol,1994,48:1413-1419.
4Yalowitz JA,Jayaram HN.Molecular targets of guanine nucleotides in differentiation,proliferation,and apoptosis.Anticancer Res,2000,20:2329-2338.
5Jayaram HN,Grusch M,Cooney DA,et al.Consequences of IMP dehydrogenase inhibition,and its relationship to cancer and apoptosis.Curr Med Chem,1999,6:561-574.
6Salamon A,Hagenauer B,Thalhammer T,et al.Metabolism and disposition of the novel antileukaemic drug,benzamide riboside,in the isolated perfused rat liver.Life Sci,2001,69:2489-2502.
7Gharehbaghi K,Paull KD,Kelley JA,et al.Cytotoxicity and characterization of an active metabolite of benzamide riboside,a novel inhibitor of IMP dehydrogenase.Int J Cancer,1994,56:892-899.
